Recommendations released from the Clinical Pharmacogenomics Implementation Consortium (CPIC) advise against administering codeine to ultrarapid metabolizers, wherever this genetic details is obtainable. The CPIC also indicates that codeine use be prevented in poor metabolizers, as a consequence of its lack of efficacy Within this team.[forty one]En